Sort
15,842 grants matching “pancreatic cancer”
Role of FH loss in development of HLRCC heriditary kidney cancer
$673,377Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The NYU Women's Health Study
$673,313Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2019 · CA
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
$673,220Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2021 · CA
Clinical Trials with Immunotoxins
$673,145Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
$673,034Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · DE
Early Diagnosis of Pancreatic Cancer
$672,897Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2007 · CA
Impact of Circadian-Microbiome Interaction on the Gut-Pancreas Axis in Aging
$671,922Faraz Bishehsari · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · AG
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$671,746Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R42 · FY2022 · CA
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers
$671,698Brian B Haab · Van Andel Research Institute · U01 · FY2020 · CA
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study
$671,593Michael G. Goggins · Johns Hopkins University · U01 · FY2024 · CA
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
$671,441John L Humm · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
$671,429Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$670,936Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$670,756Timothy A Marlowe · Faknostics, Llc · R42 · FY2022 · CA
Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer
$670,223Jeremy William Gordon · University Of California, San Francisco · R01 · FY2024 · CA
Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer
$670,223Jeremy William Gordon · University Of California, San Francisco · R01 · FY2025 · CA
THE SURVIVAL FACTOR RENALASE AND PANCREATIC CANCER
$669,999Yale Univ · · FY2019 · Department of the Army
Imaging Acidosis and Immune Therapy in PDAC
$669,832Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Imaging Acidosis and Immune Therapy in PDAC
$669,832Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
DCE-MRI guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
$669,747Harrison Kim · University Of Alabama At Birmingham · R01 · FY2024 · CA
Imaging Modulation of Immune Phenotype
$669,526Katherine W Ferrara · Stanford University · R01 · FY2021 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$669,436Dung T Le · Johns Hopkins University · P01 · FY2021 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$669,436Dung T Le · Johns Hopkins University · P01 · FY2025 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$669,180David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2024 · CA
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$669,165Evan L Fogel · Indiana University Indianapolis · U01 · FY2019 · DK